Tech Company Financing Transactions

Geneos Therapeutics Funding Round

Geneos Therapeutics secured a $12 million Series A funding round on 3/10/2021. Investors included Global BIO Impact Fund, Korea Investment Partners and Inovio Pharmaceuticals.

Transaction Overview

Company Name
Geneos Therapeutics
Announced On
3/10/2021
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series A
Investors

Global BIO Impact Fund (Lead Investor)

Korea Investment Partners (Lead Investor) (Sangwoo Lee)

Inovio Pharmaceuticals (Joseph Kim)

Sante Ventures (James Eadie)

Proceeds Purpose
The proceeds will be used for the expansion of the company's: GT-30 Phase Ib/IIa clinical trial evaluating its personalized neoantigen-targeting vaccine, GNOS-PV02, for treating patients with advanced hepatocellular carcinoma (HCC), a type of liver cancer.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
660 West Germantown Pike LL 100
Plymouth Meeting, PA 19462
USA
Phone
Undisclosed
Website
www.geneostx.com
Email Address
[email protected]
Overview
At Geneos Therapeutics, we believe that personalized therapies are the future of cancer treatment. Our passion is to develop personalized therapies to unleash the most powerful force against cancer -- your body's own immune system.
Profile
Geneos Therapeutics LinkedIn Company Profile
Social Media
Geneos Therapeutics Company Twitter Account
Company News
Geneos Therapeutics News
Facebook
Geneos Therapeutics on Facebook
YouTube
Geneos Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Niranjan Sardesai
  Niranjan Sardesai LinkedIn Profile  Niranjan Sardesai Twitter Account  Niranjan Sardesai News  Niranjan Sardesai on Facebook
Chief Financial Officer
Federica O'Brien
  Federica O'Brien LinkedIn Profile  Federica O'Brien Twitter Account  Federica O'Brien News  Federica O'Brien on Facebook
VP - Bus. Development
Hakim Hammach
  Hakim Hammach LinkedIn Profile  Hakim Hammach Twitter Account  Hakim Hammach News  Hakim Hammach on Facebook
VP - Operations
Joann Peters
  Joann Peters LinkedIn Profile  Joann Peters Twitter Account  Joann Peters News  Joann Peters on Facebook
VP - R & D
Alfredo Perales-Puchalt
  Alfredo Perales-Puchalt LinkedIn Profile  Alfredo Perales-Puchalt Twitter Account  Alfredo Perales-Puchalt News  Alfredo Perales-Puchalt on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/10/2021: WorkOS venture capital transaction
Next: 3/10/2021: Refraction AI venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to record every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.